A hydrocarbon compound and carbon monoxide are reacted in the presence of either a supported chromium (VI) catalyst or a supported chromium (II) catalyst, optionally with UV-visible light irradiation and/or exposure to an oxidizing atmosphere, followed by removing a reaction product containing an alcohol compound and/or a carbonyl compound from the respective chromium catalyst. Often, the reaction product contains one or more ketone and/or aldehyde compounds.

The present invention relates to, according to a primary aspect, a method for manufacturing a mixture comprising rotundone. A further aspect of the present invention relates to mixtures containing rotundone as well as their use for generating, imparting or modifying, preferably enhancing, one or several taste and/or olfactory impressions. Moreover, the invention relates to a pharmaceutical preparation for nutrition, for oral care or for pleasure or a cosmetic pharmaceutical preparation or a pharmaceutical preparation intended for oral consumption or an intermediate good for manufacturing a pharmaceutical preparation for nutrition, for oral care or for pleasure or a cosmetic pharmaceutical preparation or a pharmaceutical preparation intended for oral consumption comprising a mixture according to the invention and furthermore to a method for manufacturing said preparation or intermediate good.

The present invention relates to, according to a primary aspect, a method for manufacturing a mixture comprising rotundone. A further aspect of the present invention relates to mixtures containing rotundone as well as their use for generating, imparting or modifying, preferably enhancing, one or several taste and/or olfactory impressions. Moreover, the invention relates to a pharmaceutical preparation for nutrition, for oral care or for pleasure or a cosmetic pharmaceutical preparation or a pharmaceutical preparation intended for oral consumption or an intermediate good for manufacturing a pharmaceutical preparation for nutrition, for oral care or for pleasure or a cosmetic pharmaceutical preparation or a pharmaceutical preparation intended for oral consumption comprising a mixture according to the invention and furthermore to a method for manufacturing said preparation or intermediate good.

Described are compositions and methods for inhibiting polymerization of a monomer (e.g., styrene) composition a quinone methide polymerization retarder and an oxygen-containing amine compound that is a tertiary amine or hydroxylamine. In a mixture, the oxygen-containing amine compound improves the efficacy of the quinone methide polymerization retarder and provides greater antipolymerant activity. In turn, the mixture reduces or prevents apparatus fouling and improves the purity of monomer streams.

An allylic oxidation process includes forming a mixture containing -Guaiene and an iron (III)-X porphyrin complex catalyst in a sustainable solvent, introducing molecular oxygen into the mixture, and effecting allylic oxidation to produce an ,-unsaturated ketone, Rotundone.

An allylic oxidation process includes forming a mixture containing -Guaiene and an iron (III)-X porphyrin complex catalyst in a sustainable solvent, introducing molecular oxygen into the mixture, and effecting allylic oxidation to produce an ,-unsaturated ketone, Rotundone.

The present invention provides compounds as PPAR agonists and their application, involving a new class of peroxisome proliferator-activated receptor (PPAR) gamma receptor agonist, which can inhibit the production of mitochondrial reactive oxygen species, and most of which can readily cross the blood-brain barrier. The present invention also includes pharmaceutical uses of the compounds.

The present invention provides compounds as PPAR agonists and their application, involving a new class of peroxisome proliferator-activated receptor (PPAR) gamma receptor agonist, which can inhibit the production of mitochondrial reactive oxygen species, and most of which can readily cross the blood-brain barrier. The present invention also includes pharmaceutical uses of the compounds.

A method for producing a cyclohexanone dimer is provided. The method includes the steps of performing condensation of cyclohexanone in the presence of a solid acid catalyst to obtain the cyclohexanone dimer, wherein the solid acid catalyst includes metal oxide of tungsten and a carrier with Lewis acid sites and Brnsted acid sites. The method of the present disclosure has an advantage of mild reaction condition, fast reaction rate and high selectivity, thereby realizing the value of the industrial application.

A method for producing a cyclohexanone dimer is provided. The method includes the steps of performing condensation of cyclohexanone in the presence of a solid acid catalyst to obtain the cyclohexanone dimer, wherein the solid acid catalyst includes metal oxide of tungsten and a carrier with Lewis acid sites and Brnsted acid sites. The method of the present disclosure has an advantage of mild reaction condition, fast reaction rate and high selectivity, thereby realizing the value of the industrial application.